OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN
Objective: To study the outcomes of allo-HCT in patients with hematological malignancy who received BU3 (9.6 mg/kg) based conditioning from matched related or unrelated donors. Methodology: A retrospective analysis of KFSHRC- BMT Database, we identified 65 patients who received Allo-HCT between Octo...
Guardado en:
Autores principales: | Majed Altareb, Yazeed Bajuaifer, Walid Rasheed |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/990786919fe843c4b5cddd2870568c6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Ömer Faruk Bahçecioğlu, et al.
Publicado: (2021) -
THE ROLE OF THERAPEUTIC DRUG MONITORING OF INTRAVENOUS BUSULFAN FOR PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME IN CHILDREN
por: Dilek GURLEK GOKCEBAY, et al.
Publicado: (2021) -
Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021) -
HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA
por: Arnon Nagler
Publicado: (2021) -
HEMATOLOGIC REFERENCE VALUES FOR HEALTHY ADULT SAUDIS
por: Salwa Bakr
Publicado: (2021)